Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 330.04%374.26M | -379.75%-162.69M | -90.22%58.16M | 185.59%594.81M | -67.81%208.28M | 112.76%647.07M | -10.03%304.13M | 20.33%338.05M | 6.52%280.93M | 212.35%263.74M |
Net profit before non-cash adjustment | 182.67%234.03M | -203.25%-283.08M | 7.78%274.18M | 23.11%254.38M | -42.37%206.63M | 55.57%358.57M | 22.10%230.48M | 361.40%188.76M | -82.10%40.91M | 9.69%228.58M |
Total adjustment of non-cash items | 5.69%317.05M | 14.43%299.97M | 7.77%262.14M | -15.13%243.24M | 48.75%286.59M | 17.79%192.67M | 14.03%163.57M | 13.39%143.45M | -5.61%126.51M | -22.25%134.02M |
-Depreciation and amortization | 2.00%318.5M | 19.79%312.25M | 2.43%260.66M | -6.40%254.46M | 35.86%271.87M | 35.52%200.11M | 1.57%147.67M | -4.27%145.38M | 1.19%151.87M | 2.04%150.08M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -476.63%-14.5M | 109.84%3.85M |
-Disposal profit | 552.07%6.54M | -108.40%-1.45M | 235.07%17.21M | -55.77%5.14M | 545.80%11.61M | -148.01%-2.61M | 424.33%5.43M | -657.01%-1.67M | 95.09%-221K | 68.72%-4.5M |
-Net exchange gains and losses | -6.54%-13.52M | 27.19%-12.69M | -694.07%-17.42M | -235.18%-2.19M | 154.83%1.62M | -123.43%-2.96M | 1,308.03%12.64M | -127.71%-1.05M | 172.10%3.78M | -159.98%-5.24M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -39.86%-12.61M | ---9.02M |
-Other non-cash items | 197.15%5.53M | 9.99%1.86M | 111.94%1.69M | -1,052.83%-14.16M | 179.08%1.49M | 12.81%-1.88M | -374.17%-2.16M | 143.69%786K | -55.49%-1.8M | -101.43%-1.16M |
Changes in working capital | 1.54%-176.82M | 62.44%-179.58M | -592.03%-478.16M | 134.11%97.18M | -397.34%-284.95M | 206.56%95.83M | -1,639.44%-89.93M | -94.85%5.84M | 214.82%113.51M | 83.94%-98.86M |
-Change in receivables | -143.10%-147.8M | 284.20%342.94M | -47.77%-186.18M | -244.59%-126M | -35.31%87.14M | 181.10%134.71M | -22.06%-166.1M | -257.69%-136.08M | 468.68%86.29M | 105.31%15.17M |
-Change in inventory | -23.27%152.82M | 165.35%199.17M | -1,037.51%-304.76M | -86.79%32.51M | 1,069.68%246M | 108.12%21.03M | -121.38%-258.98M | -146.75%-116.98M | 229.60%250.24M | 28.29%-193.09M |
-Change in payables | 48.09%-243.57M | -600.33%-469.24M | -0.94%93.79M | 118.76%94.68M | -267.10%-504.73M | -139.49%-137.49M | 34.29%348.12M | 200.61%259.24M | -495.59%-257.67M | 1,426.12%65.14M |
-Provision for loans, leases and other losses | -193.61%-67.92M | 243.50%72.56M | -235.87%-50.56M | 156.42%37.22M | -972.95%-65.97M | -125.13%-6.15M | -41.83%24.47M | --42.06M | ---- | ---- |
-Changes in other current assets | 148.84%117.15M | -143.67%-239.85M | -1,012.34%-98.43M | 680.37%10.79M | -105.73%-1.86M | 191.50%32.43M | 51.95%-35.44M | -312.90%-73.77M | 148.89%34.65M | 121.44%13.92M |
-Changes in other current liabilities | 114.69%12.51M | -225.25%-85.16M | 41.68%67.99M | 205.42%47.99M | -188.74%-45.52M | 2,657.43%51.3M | -106.39%-2.01M | --31.38M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -46.09%-9.16M | -22.71%-6.27M | 15.14%-5.11M | -30.19%-6.02M | -369.27%-4.63M | -113.42%-986K | 37.90%-462K | 31.99%-744K | 5.93%-1.09M | 45.96%-1.16M |
Interest received (cash flow from operating activities) | -5.68%5.29M | 28.66%5.6M | -11.18%4.36M | 15.61%4.9M | -12.27%4.24M | 1.43%4.83M | -1.57%4.77M | -3.57%4.84M | 30.86%5.02M | -40.50%3.84M |
Tax refund paid | 129.49%32.39M | 4.65%-109.86M | -968.85%-115.21M | 90.16%-10.78M | -92.12%-109.5M | 17.81%-57M | -1,816.11%-69.34M | 86.16%-3.62M | 20.77%-26.14M | -67.52%-33M |
Other operating cash inflow (outflow) | 0 | 20,353,000.00%203.53M | -99.99%1K | 16.03M | 0 | 0.00%-1K | -200.00%-1K | 200.00%1K | -1K | 0 |
Operating cash flow | 677.96%402.77M | -20.55%-69.69M | -109.65%-57.81M | 508.76%598.94M | -83.43%98.39M | 148.41%593.92M | -29.38%239.09M | 30.85%338.53M | 10.84%258.71M | 193.31%233.42M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 43.21%-227.17M | -42.39%-400.05M | -70.34%-280.95M | 25.80%-164.94M | 20.98%-222.28M | -34.04%-281.3M | -64.98%-209.86M | 45.70%-127.2M | -322.96%-234.28M | -163.06%-55.39M |
Net intangibles purchase and sale | --0 | -1,525.60%-27.31M | -250.00%-1.68M | 92.31%-480K | 2.07%-6.24M | -121.60%-6.37M | ---2.88M | ---- | ---- | ---- |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---10.8M | ---- | ---- | ---- | ---- | ---- |
Net investment product transactions | 519.38%67.29M | 108.88%10.86M | -277.08%-122.29M | -151.74%-32.43M | -1,368.99%-12.88M | 97.76%-877K | -8.01%-39.11M | 7.11%-36.21M | 4.47%-38.98M | 2.90%-40.81M |
Net changes in other investments | 89.96%-947K | -258.56%-9.43M | 2,063.27%5.95M | 115.26%275K | -539.01%-1.8M | -110.83%-282K | 5,205.88%2.6M | -100.05%-51K | 333,163.33%99.98M | -99.87%30K |
Investing cash flow | 62.24%-160.83M | -6.76%-425.93M | -101.93%-398.97M | 22.22%-197.57M | 12.06%-254.01M | -15.88%-288.83M | -52.48%-249.24M | 5.67%-163.46M | -80.19%-173.28M | -278.58%-96.17M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -132.66%-214.18M | 518.69%655.86M | -140.20%-156.65M | -122.90%-65.22M | 209.59%284.82M | 647.62%92M | 0.00%-16.8M | -150.00%-16.8M | 300.00%33.6M | 85.64%-16.8M |
Net common stock issuance | --0 | -21.00%-45.15M | 37.93%-37.31M | -76.12%-60.12M | -14,613.79%-34.14M | 54.51%-232K | -218.75%-510K | 59.49%-160K | ---395K | ---- |
Cash dividends paid | 27.18%-66.76M | 1.57%-91.68M | -0.98%-93.14M | -12.07%-92.23M | -18.17%-82.29M | -9.98%-69.64M | -24.99%-63.32M | 27.29%-50.66M | -37.50%-69.68M | -33.33%-50.67M |
Net other fund-raising expenses | ---- | ---2K | ---- | 0.00%-1K | 50.00%-1K | ---2K | ---- | 0.00%-1K | ---1K | ---- |
Financing cash flow | -154.13%-280.95M | 280.79%519.03M | -31.96%-287.1M | -229.20%-217.56M | 661.05%168.39M | 127.44%22.13M | -19.24%-80.63M | -85.41%-67.62M | 45.95%-36.47M | 56.48%-67.47M |
Net cash flow | ||||||||||
Beginning cash position | 4.03%1.7B | -30.09%1.63B | 7.97%2.33B | 3.55%2.16B | 18.40%2.09B | -5.90%1.76B | 5.56%1.87B | 2.62%1.77B | 6.24%1.73B | -15.12%1.63B |
Current changes in cash | -266.63%-39.01M | 103.15%23.41M | -504.71%-743.88M | 1,339.34%183.8M | -96.10%12.77M | 460.41%327.21M | -184.50%-90.79M | 119.46%107.44M | -29.84%48.96M | 119.86%69.78M |
Effect of exchange rate changes | -9.39%38.36M | 1.38%42.34M | 459.99%41.76M | -163.18%-11.6M | -53.59%-4.41M | 85.41%-2.87M | -121.65%-19.67M | -140.16%-8.87M | -111.63%-3.7M | -48.17%31.78M |
Cash adjustments other than cash changes | ---- | ---- | ---2K | ---- | 6,577,500.00%65.78M | 200.00%1K | 0.00%-1K | 0.00%-1K | ---1K | ---- |
End cash Position | -0.04%1.7B | 4.03%1.7B | -30.09%1.63B | 7.97%2.33B | 3.55%2.16B | 18.40%2.09B | -5.90%1.76B | 5.56%1.87B | 2.62%1.77B | 6.24%1.73B |
Free cash flow | 133.40%168.44M | -47.26%-504.27M | -179.54%-342.43M | 424.52%430.5M | -144.54%-132.66M | 1,085.79%297.86M | -87.89%25.12M | 807.61%207.43M | -87.03%22.85M | 150.71%176.22M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |